Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Verrica Pharmaceuticals Announces Private Placement Financing of $50 Million to Retire Debt and Extend... (GlobeNewswire EN) +++ VERRICA Aktie +7,40%

EVOKE Aktie

 >EVOKE Aktienkurs 
0.418 EUR    +7.3%    (Tradegate)
Ask: 0.418 EUR / 24000 Stück
Bid: 0.409 EUR / 24500 Stück
Tagesumsatz: 7000 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
EVOKE Aktie über LYNX handeln
>EVOKE Performance
1 Woche: -2,5%
1 Monat: -18,4%
3 Monate: -42,7%
6 Monate: -40,9%
1 Jahr: -36,6%
laufendes Jahr: -47,1%
>EVOKE Aktie
Name:  EVOKE PLC LS-,005
Land:  Großbritannien
Sektor:  Medien / Erholung
ISIN/ Wkn:  GI000A0F6407 / A0F640
Symbol/ Ticker:  C8V (Frankfurt)
Kürzel:  FRA:C8V, ETR:C8V, C8V:GR
Index:  -
Webseite:  https://www.evokeplc.com/
Profil:  Evoke PLC is a prominent player in the global gami..
>Volltext..
Marktkapitalisierung:  173.5 Mio. EUR
Unternehmenswert:  2042.22 Mio. EUR
Umsatz:  2122.68 Mio. EUR
EBITDA:  418.03 Mio. EUR
Nettogewinn:  -135.09 Mio. EUR
Gewinn je Aktie:  -0.3 EUR
Schulden:  2175.02 Mio. EUR
Liquide Mittel:  289.61 Mio. EUR
Operativer Cashflow:  124.6 Mio. EUR
Bargeldquote:  0.34
Umsatzwachstum:  3.93%
Gewinnwachstum:  33.06%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Div. Historie:  16.09.21 - 0.03802898€
25.03.21 - 0.09826812€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  EVOKE, 888 HOLDINGS, 888 HOLDING
Letzte Datenerhebung:  24.11.25
>EVOKE Kennzahlen
Aktien/ Unternehmen:
Aktien: 448.26 Mio. St.
Frei handelbar: 79.78%
Rückkaufquote: -
Mitarbeiter: 10622
Umsatz/Mitarb.: 0.18 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 159.88%
Bewertung:
KGV: -
KGV lG: 2.99
KUV: 0.09
KBV: -
PEG-Ratio: -
EV/EBITDA: 4.89
Rentabilität:
Bruttomarge: 53.99%
Gewinnmarge: -6.36%
Operative Marge: 7.22%
Managementeffizenz:
Gesamtkaprendite: -4.32%
Eigenkaprendite: -
>EVOKE Peer Group

Es sind 42 Aktien bekannt.
 
24.11.25 - 13:24
Wdh: Abnehmmittel als Alzheimer-Hoffnung: Novo Nordisk enttäuscht mit Studie (Cash)
 
- Das Abnehmmittel Semaglutid des Pharmakonzerns Novo Nordisk hat in einer Alzheimer-Studie nicht den erwünschten Erfolg gebracht. Die zulassungsrelevante Phase-III-Studie Evoke zu Semaglutid in oraler Darreichungsform habe im Vergleich zu Placebo keine statistisch signifikante Verlangsamung des Fortschreitens der Alzheimer-Krankheit gezeigt, teilte der dänische Pharmariese am Montag mit. Der Aktienkurs von Novo Nordisk brach auf die Nachricht hin um zehn Prozent auf den tiefsten Stand seit dem Jahr 2021 ein./mis/stw...
24.11.25 - 13:09
Novo Nordisk scheitert bei Alzheimer – Aktie rauscht nach unten (Der Aktionaer)
 
Die Aktie von Novo Nordisk rauscht zum Wochenstart ordentlich nach unten. Der Grund: Die Studien zu Rybelsus, basierend auf dem Wirkstoff Semaglutid, zum Einsatz bei Alzheimer zeigten nicht den erhofften Erfolg. In den Studien Evoke und Evoke+ konnte keine Verlangsamung des Krankheitsfortschritts erzielt werden....
24.11.25 - 13:01
Abnehmmittel als Alzheimer-Hoffnung: Novo Nordisk enttäuscht mit Studie (DPA-AFX)
 
BAGSVAERD (dpa-AFX) - Das Abnehmmittel Wegovy des Pharmakonzerns Novo Nordisk hat in einer Alzheimer-Studie nicht den erwünschten Erfolg gebracht. Die zulassungsrelevante Phase-III-Studie Evoke habe im Vergleich ......
24.11.25 - 13:01
Novo Nordisk: EVOKE-Flop löst massiven Abverkauf aus (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
24.11.25 - 12:54
Novo Nordisk enttäuscht mit Alzheimer-Studie (Cash)
 
- Das Abnehmmittel Wegovy des Pharmakonzerns Novo Nordisk hat in einer Alzheimer-Studie nicht den erwünschten Erfolg gebracht. Die zulassungsrelevante Phase-III-Studie Evoke habe im Vergleich zu Placebo keine statistisch signifikante Verlangsamung des Fortschreitens der Alzheimer-Krankheit gezeigt, teilte der dänische Pharmariese am Montag mit. Der Aktienkurs von Novo Nordisk brach auf die Nachricht hin um zehn Prozent auf den tiefsten Stand seit dem Jahr 2021 ein./mis/stw...
24.11.25 - 12:24
Novo Nordisk A/S: Evoke phase 3 trials did not demonstrate a statistically significant reduction in Alzheimer′s disease progression (GlobeNewswire EN)
 
Bagsværd, Denmark, 24 November 2025 – Novo Nordisk today announced the top-line results from the 2-year primary analysis of evoke and evoke+ phase 3 trials in early-stage symptomatic Alzheimer's disease. The two trials were randomised, double-blinded, enrolled a total of 3808 adults and evaluated the efficacy and safety of oral semaglutide compared to placebo on top of standard of care. The decision to pursue an Alzheimer's disease indication with semaglutide was based on real-world evidence studies, pre-clinical models as well as post-hoc analyses from diabetes and obesity trials....
04.11.25 - 17:30
Shareholder Alert: The Ademi Firm investigates whether Evoke Pharma Inc. is obtaining a Fair Price for its Public Shareholders (PR Newswire)
 
MILWAUKEE, Nov. 4, 2025 /PRNewswire/ -- The Ademi Firm is investigating Evoke (NASDAQ: EVOK) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction. Click here to learn how to join our investigation and obtain additional information or......
03.11.25 - 15:12
MAI Capital Management Announces Expanded Office of Managing Partners Appointments Following Strategic Acquisition of Evoke Advisors (Business Wire)
 
Partnership creates national RIA with 600 employees and $65 billion in AUMCLEVELAND--(BUSINESS WIRE)--MAI Capital Management (“MAI”), a registered investment advisor (RIA) focused on empowering clients to simplify, protect and grow their wealth, today announced it has completed its strategic partnership with Los Angeles-based RIA Evoke Advisors (“Evoke”). As part of this acquisition, MAI is introducing new Managing Partner appointments to help guide the firm's next chapter of growth and innovation. With the completion of the acquisition, MAI scales to over $65 billion in assets under management (AUM) across 34 offices nationwide. This marks a landmark year for the firm, during which it has added over $30 billion in AUM and expanded its services for ultra-high-net-worth (UHNW) individuals, families and institutions. Integrating talent from both MAI and Evoke, the newly expanded Managing Partner team embodies MAI's dedication to delivering exceptional service and deep expertise for its full roster...
29.10.25 - 00:30
Evoke 1 Punters 0: Unpredictable Premier League results hand William Hill owner a huge profits boost (DailyMail)
 
The start of this football season has seen success for little-fancied sides such as Sunderland (pictured) rubbing shoulders with the more established names...
28.10.25 - 13:18
Evoke eyes above consensus earnings but looming budget pegs back stock (Alliance)
 
Evoke PLC on Tuesday said it expects to report adjusted earnings ahead of expectations, after a strong third quarter which...
28.10.25 - 09:57
Evoke shares surge as company reaffirms guidance, beats expectations (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
22.10.25 - 17:09
EVOKE: An Experience Agency Welcomes Hospitality Industry Powerhouse Michelle Fossett as Vice President (PR Newswire)
 
Reuniting Two Former Agency Leaders to Redefine Experiential Marketing HOUSTON, Oct. 22, 2025 /PRNewswire/ -- EVOKE: An Experience Agency, the rapidly growing Texas-based experiential marketing and brand merchandising firm founded by Oana Borcoman, proudly announces the appointment of......
21.10.25 - 19:24
Evoke chair Mendelsohn steps down (ShareCast)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
21.10.25 - 12:06
SMALL-CAP WINNERS & LOSERS: Gulf Marine revenue up; Evoke chair exits (Alliance)
 
The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday....
20.10.25 - 14:36
It′s still killing people, and the government has yet to act: Britain′s hidden asbestos epidemic | Tom White (The Guardian)
 
Asbestos was banned in 1999, but as materials left in our buildings deteriorate, thousands of lives are being lost every yearHelen Bone was diagnosed with an asbestos-related cancer in 2021. She was 38. The type of cancer, mesothelioma, is incurable; the best prognosis is a few years, though most people don't get that long. “You always think of asbestos as a disease from decades ago – affecting men who worked in heavy industry – so to be diagnosed in my 30s is shocking,” she told the Northern Echo in 2022. “I want to see my children grow up but now I have to come to terms with the thought that this might not happen.” Sadly, Bone passed away in November last year, just three years after her diagnosis.For most people, the word “asbestos” will evoke previous eras: dusty Victorian and Edwardian factories; the shipyards of the interwar period; postwar building sites. Yet asbestos was not banned in the UK until 1999. According to the Health and Safety Executive (HSE), it still kills around 5,00...
17.10.25 - 07:30
Spa vibes with a grow-your-own-dinner option: Britain′s best new building is a revamped almshouse (The Guardian)
 
With its shimmering ginkgo trees, tinkling pools and a rooftop garden, the Appleby Blue Almshouse housing complex for older people is a worthy winner of RIBA's prestigious Stirling prizeDescribed as “a provision of pure delight”, Appleby Blue Almshouse, a social housing complex for older people has been named this year's winner of the RIBA Stirling prize. With a vibe that has more in common with an Alpine spa hotel than the poky rooms and grim corridors usually associated with housing for elderly people, the building – by architects Witherford Watson Mann – reinvents the almshouse for the modern era as a place of care, shelter and social connection.As a building type, the origins of almshouses extend back centuries, giving a semblance of dignity to the poor, the old, the sick and the marginalised. Sequestered from the outside world, with cellular dwellings arrayed around courtyards, they evoke a sense of pastoral benevolence. Continue reading......
13.10.25 - 10:24
William Hill owner Evoke threatens betting shop closures if taxes go up (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
12.10.25 - 18:18
William Hill owner says it could shut up to 200 shops if Reeves raises gambling taxes (The Guardian)
 
Evoke considering the plans before expected tax increases in budget, with up to 1,500 jobs potentially affectedThe debt-laden company behind William Hill is considering closing up to 200 betting shops if Rachel Reeves's autumn budget raises taxes on the gambling sector.Evoke, formerly known as 888, which acquired William Hill in a £2bn takeover in 2022, is drawing up plans for different scenarios before expected gambling tax increases in the chancellor's budget on 26 November. Continue reading......
08.10.25 - 15:09
MAI Capital Management Doubles Down on Organic Growth; Announces New Chief Marketing Officer (Business Wire)
 
Former Focus Financial Partners executive to lead end-to-end client experience marketing strategy and advisor enablement initiativesCLEVELAND--(BUSINESS WIRE)--MAI Capital Management (“MAI”), a registered investment advisor (RIA) focused on empowering clients to simplify, protect and grow their wealth, today announced the hiring of Kathleen Alcorn as Chief Marketing Officer (“CMO”). Alcorn's appointment signals the latest step in MAI's strategy to elevate the firm into an industry-leading RIA, building on the momentum of its acquisition of Los Angeles-based Evoke Advisors. By investing in firms and talent that strengthen its national presence, MAI is enhancing both the client and advisor experience, while positioning the company for sustained growth. Alcorn brings more than two decades of financial services marketing experience to MAI's leadership team. She has served as CMO at Focus Financial Partners and Nasdaq Corporate Solutions, where she was instrumental in building global brands and lead...
17.09.25 - 08:24
Global Times: Guangxi accelerates building an international AI cooperation hub focusing on ASEAN (PR Newswire)
 
BEIJING, Sept. 17, 2025 /PRNewswire/ -- In a lush park northwest of Nanning's bustling center, exotic architecture and serene landscapes evoke a tourist haven. Yet, step inside an exhibition hall, and a cutting-edge world unfolds, showcasing over 110 high-tech innovations, from drones and......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Liebe kann alles, Geld besiegt alles, die Zeit zehrt alles auf, und der Tod endet alles. - Sprichwort Italien
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!